Novartis Institutes for Biomedical Research, Inc.
Patent reexamination counsel·4 ex parte reexams
Novartis Institutes for Biomedical Research, Inc. has served as patent-owner counsel in 4 USPTO ex parte reexaminations, with 4 currently open. The firm most often represents Advanced Accelerator Applications SA. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top patent owners represented
Outcome track record
How this firm's reexams resolve once a certificate issues: all claims confirmed, amended, mixed, or canceled.
- Certificate outcome split across every bucket
- Share of proceedings where claims survived
Practice metrics
Certificate rate, average pendency, and the open/closed split across the firm's full reexam docket.
- Certificate rate of closed proceedings
- Average pendency in months
Examiners & adversaries
Which examiners most often decide this firm's reexams, and which requesters most often challenge its patents.
- Most frequent examiners
- Top opposing requesters
Recent reexaminations (4)
| Control # | Filed | Patent | Title | Owner | Status |
|---|---|---|---|---|---|
| 90/016,154 | Apr 3, 2026 | 12,151,003 | Stable, concentrated radionuclide complex solutions | Advanced Accelerator Applications SA | Open |
| 90/016,039 | Mar 11, 2026 | 12,168,063 | Stable, concentrated radionuclide complex solutions | Advanced Accelerator Applications SA | Open |
| 90/015,965 | Feb 17, 2026 | 12,415,003 | Stable, concentrated radionuclide complex solutions | Advanced Accelerator Applications SA | Open |
| 90/015,460 | Aug 18, 2025 | 12,144,873 | Stable, concentrated radionuclide complex solutions | Advanced Accelerator Applications SA | Open |
Other reexam law firms
See the full reexam picture for Novartis Institutes for Biomedical Research, Inc.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.